Temasek Holdings (Private) LTD Karuna Therapeutics, Inc. Transaction History

Temasek Holdings (Private) LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $647,739 - $820,505	-4,015 Reduced 19.54%	16,535 $3 Million
Q4 2022 May 15, 2023	SELL	$191.53 - $236.82 $3.94 Million - $4.87 Million	-20,548 Reduced 50.0%	20,550 $4.04 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $3.94 Million - $4.87 Million	-20,548 Reduced 50.0%	20,550 $4.04 Million
Q3 2022 May 15, 2023	BUY	$123.79 - $277.42 $2.54 Million - $5.7 Million	20,548 Added 99.99%	41,098 $9.24 Million
Q3 2022 Apr 05, 2023	BUY	$123.79 - $277.42 $2.54 Million - $5.7 Million	20,548 Added 99.99%	41,098 $9.24 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $5.09 Million - $11.4 Million	41,098 New	41,098 $9.24 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $1.42 Million - $2.05 Million	-12,844 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $690,043 - $873,070	6,422 Added 100.0%	12,844 $1.46 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $613,044 - $854,639	6,422 New	6,422 $772,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

Stay updated on Temasek Holdings (Private) LTD with notifications on news.